Research statistics
Thymosin Alpha-1 research: publications and trials
At a glance
Publications, all years
782
Since 1977
Publications in 2026 so far
20
Through November 15, 2026
Human clinical research
27.3%
208 of 762 classified
Registered clinical trials
60
ClinicalTrials.gov
Randomized controlled trials
73
Publications reporting an RCT in people
Systematic reviews and meta-analyses
23
Preclinical studies
54.1%
258 animal · 148 in vitro · 6 computational
Records that only mention it
182
Not counted above
Status in the library: Research only. Groups: Thymic peptides. 20 publications are not yet classified by study type.
What to keep in mind
- Some completed trials have neither posted results nor a linked results publication.
- The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.
Publications by year
Thymosin Alpha-1 publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1977 | 0 | 1 | 0 | 0 | 1 |
| 1978 | 0 | 1 | 0 | 0 | 1 |
| 1979 | 0 | 3 | 0 | 2 | 5 |
| 1980 | 0 | 3 | 0 | 3 | 6 |
| 1981 | 1 | 6 | 1 | 2 | 10 |
| 1982 | 0 | 8 | 0 | 2 | 10 |
| 1983 | 3 | 18 | 1 | 4 | 26 |
| 1984 | 6 | 15 | 1 | 1 | 23 |
| 1985 | 5 | 18 | 3 | 2 | 28 |
| 1986 | 3 | 11 | 0 | 0 | 14 |
| 1987 | 4 | 16 | 1 | 3 | 24 |
| 1988 | 3 | 16 | 0 | 0 | 19 |
| 1989 | 5 | 16 | 1 | 0 | 22 |
| 1990 | 1 | 12 | 0 | 0 | 13 |
| 1991 | 3 | 9 | 0 | 0 | 12 |
| 1992 | 1 | 16 | 1 | 1 | 19 |
| 1993 | 3 | 6 | 0 | 0 | 9 |
| 1994 | 2 | 6 | 2 | 1 | 11 |
| 1995 | 3 | 8 | 1 | 0 | 12 |
| 1996 | 9 | 9 | 0 | 2 | 20 |
| 1997 | 1 | 7 | 1 | 2 | 11 |
| 1998 | 5 | 6 | 1 | 0 | 12 |
| 1999 | 2 | 5 | 2 | 1 | 10 |
| 2000 | 6 | 7 | 5 | 1 | 19 |
| 2001 | 3 | 4 | 1 | 0 | 8 |
| 2002 | 4 | 6 | 2 | 2 | 14 |
| 2003 | 4 | 4 | 4 | 0 | 12 |
| 2004 | 9 | 7 | 4 | 1 | 21 |
| 2005 | 5 | 14 | 2 | 0 | 21 |
| 2006 | 7 | 5 | 0 | 1 | 13 |
| 2007 | 9 | 13 | 4 | 2 | 28 |
| 2008 | 6 | 6 | 0 | 0 | 12 |
| 2009 | 7 | 8 | 6 | 1 | 22 |
| 2010 | 4 | 5 | 10 | 1 | 20 |
| 2011 | 5 | 8 | 3 | 0 | 16 |
| 2012 | 3 | 6 | 7 | 0 | 16 |
| 2013 | 2 | 6 | 1 | 0 | 9 |
| 2014 | 1 | 3 | 1 | 0 | 5 |
| 2015 | 5 | 17 | 3 | 2 | 27 |
| 2016 | 4 | 4 | 7 | 0 | 15 |
| 2017 | 2 | 7 | 2 | 2 | 13 |
| 2018 | 4 | 12 | 7 | 3 | 26 |
| 2019 | 3 | 9 | 2 | 0 | 14 |
| 2020 | 7 | 10 | 4 | 2 | 23 |
| 2021 | 6 | 4 | 4 | 0 | 14 |
| 2022 | 11 | 5 | 1 | 1 | 18 |
| 2023 | 9 | 11 | 6 | 0 | 26 |
| 2024 | 6 | 3 | 3 | 0 | 12 |
| 2025 | 10 | 5 | 4 | 1 | 20 |
| 2026 (to date) | 6 | 7 | 6 | 1 | 20 |
Study types
| Animal study | 258 |
|---|---|
| In vitro study | 148 |
| Review | 92 |
| Randomized controlled trial | 73 |
| Observational human study | 67 |
| Other clinical trial | 52 |
| Editorial, letter or other | 27 |
| Meta-analysis | 22 |
| Not yet classified | 20 |
| Case report | 16 |
| Computational study | 6 |
| Systematic review | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Immune system | 396 |
|---|---|
| Antimicrobial and infectious disease | 240 |
| Oncology | 195 |
| Gastrointestinal | 152 |
| Endocrinology | 34 |
| Reproductive and sexual health | 34 |
| Longevity and aging | 28 |
| Neurological and mental health | 26 |
| Dermatology | 23 |
| Tissue repair | 17 |
| Cardiovascular | 14 |
| Metabolic health | 11 |
Registered clinical trials
6 of 17 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 23 · Unknown status: 16 · Recruiting: 8 · Not yet recruiting: 5 · Withdrawn: 4 · Active, not recruiting: 2 · Enrolling by invitation: 1 · Terminated: 1
Early phase 1: 1 · Phase not applicable: 11 · Phase 1: 2 · Phase 1 / Phase 2: 3 · Phase 2: 25 · Phase 2 / Phase 3: 1 · Phase 3: 7 · Phase 4: 10
The 50 most recently started of 60 trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Efficacy and safety of thymosin α1 combined with chemotherapy for gastric cancer: a systematic review and meta-analysis of randomized controlled trials.
Frontiers in immunology · September 18, 2026 · Meta-analysis · cited 0 times · open access
PMID 42827862 · DOI 10.3389/fimmu.2026.1884797 · Reviews and meta-analyses
- Thymosin-ɑ1 for people with chronic hepatitis B.
The Cochrane database of systematic reviews · September 9, 2026 · Meta-analysis · cited 0 times · open access
PMID 42713852 · DOI 10.1002/14651858.cd014610.pub2 · Reviews and meta-analyses
- Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.
Frontiers in cellular and infection microbiology · September 3, 2025 · Meta-analysis · cited 3 times · open access
PMID 40969554 · DOI 10.3389/fcimb.2025.1673959 · Reviews and meta-analyses
- Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.
Frontiers in immunology · June 17, 2025 · Meta-analysis · cited 4 times · open access
PMID 40599771 · DOI 10.3389/fimmu.2025.1571456 · Reviews and meta-analyses
- The Effect of Ulinastatin on Sepsis Outcomes: An Umbrella Review of Meta-Analysis.
Clinical therapeutics · March 6, 2025 · Meta-analysis · cited 1 times
PMID 40055068 · DOI 10.1016/j.clinthera.2025.01.013 · Reviews and meta-analyses
- Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · December 1, 2024 · Meta-analysis · cited 2 times · open access
PMID 39648386 · DOI 10.29271/jcpsp.2024.12.1497 · Reviews and meta-analyses
- The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression.
Inflammopharmacology · October 16, 2023 · Meta-analysis · cited 4 times
PMID 37845598 · DOI 10.1007/s10787-023-01354-2 · Reviews and meta-analyses
- Thymosin alpha1 use in adult COVID-19 patients: A systematic review and meta-analysis on clinical outcomes.
International immunopharmacology · December 13, 2022 · Meta-analysis · cited 9 times · open access
PMID 36527881 · DOI 10.1016/j.intimp.2022.109584 · Reviews and meta-analyses
- The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.
BMC gastroenterology · October 19, 2020 · Meta-analysis · cited 8 times · open access
PMID 33076834 · DOI 10.1186/s12876-020-01477-8 · Reviews and meta-analyses
- Interventions for treating traumatised permanent front teeth: avulsed (knocked out) and replanted.
The Cochrane database of systematic reviews · February 5, 2019 · Meta-analysis · cited 14 times
PMID 30720860 · DOI 10.1002/14651858.cd006542.pub3 · Reviews and meta-analyses
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Immunologic abnormalities in the acquired immunodeficiency syndrome.
Annual review of immunology · January 1, 1985 · Review · cited 380 times
PMID 2415141 · DOI 10.1146/annurev.iy.03.040185.002401 · Reviews and meta-analyses
- Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.
Proceedings of the National Academy of Sciences of the United States of America · February 1, 1977 · Animal study · cited 355 times · open access
PMID 265536 · DOI 10.1073/pnas.74.2.725 · Animal studies
- Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report.
Medicine · July 1, 2020 · Case report · cited 327 times · open access
PMID 32756149 · DOI 10.1097/md.0000000000021429 · Human clinical research
- The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.
The Journal of biological chemistry · February 1, 1979 · Animal study · cited 265 times · open access
PMID 216684 · DOI 10.1016/s0021-9258(17)37900-0 · Animal studies
- Thymosin stimulates secretion of luteinizing hormone-releasing factor.
Science (New York, N.Y.) · November 1, 1981 · Animal study · cited 253 times
PMID 7027442 · DOI 10.1126/science.7027442 · Animal studies
Latest publications
- A novel porcine interleukin-2-interferon-α-thymosin α1 tripartite fusion protein confers antiviral activity against pseudorabies virus.
Veterinary microbiology · October 8, 2026 · Animal study · cited 0 times
PMID 42858589 · DOI 10.1016/j.vetmic.2026.111247 · Animal studies
- Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.
Pharmaceuticals (Basel, Switzerland) · September 19, 2026 · Review · cited 0 times · open access
PMID 42797537 · DOI 10.3390/ph19091492 · Reviews and meta-analyses
- Efficacy and safety of thymosin α1 combined with chemotherapy for gastric cancer: a systematic review and meta-analysis of randomized controlled trials.
Frontiers in immunology · September 18, 2026 · Meta-analysis · cited 0 times · open access
PMID 42827862 · DOI 10.3389/fimmu.2026.1884797 · Reviews and meta-analyses
- Thymosin-ɑ1 for people with chronic hepatitis B.
The Cochrane database of systematic reviews · September 9, 2026 · Meta-analysis · cited 0 times · open access
PMID 42713852 · DOI 10.1002/14651858.cd014610.pub2 · Reviews and meta-analyses
- Thymosin Alpha-1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · September 3, 2026 · Animal study · cited 0 times · open access
PMID 42693587 · DOI 10.1002/advs.202522372 · Animal studies
- Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells.
Cancer research · September 1, 2026 · Animal study · cited 0 times
PMID 42295795 · DOI 10.1158/0008-5472.can-25-5547 · Animal studies
- Thymosin α-1 in cancer therapy: Immunomodulatory mechanisms, clinical applications, and translational perspectives.
European journal of pharmacology · August 26, 2026 · Review · cited 0 times
PMID 42641753 · DOI 10.1016/j.ejphar.2026.179277 · Reviews and meta-analyses
- Association between thymosin α1 therapy and 28-day mortality risk in critically ill patients with tuberculosis-related sepsis: a retrospective cohort study.
BMC infectious diseases · August 5, 2026 · Observational human study · cited 0 times · open access
PMID 42972235 · DOI 10.1186/s12879-026-14132-6 · Human clinical research
- Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro.
Asian Pacific journal of cancer prevention : APJCP · June 1, 2026 · In vitro study · cited 0 times · open access
PMID 42345155 · DOI 10.31557/apjcp.2026.27.6.2089 · In vitro studies
- Regarding IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression.
Journal of gastroenterology and hepatology · May 29, 2026 · Editorial, letter or other · cited 0 times
PMID 42212632 · DOI 10.1111/jgh.70471 · Commentary and other
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Tα1; Thymalfasin; Thymosin Alpha-1; Thymosine Alpha 1; Zadaxin
((TITLE_ABS:"Tα1" OR CHEM:"Tα1" OR TITLE_ABS:"Talpha1" OR CHEM:"Talpha1" OR TITLE_ABS:"Talpha 1" OR CHEM:"Talpha 1") OR (TITLE_ABS:"Thymalfasin" OR CHEM:"Thymalfasin") OR (TITLE_ABS:"Thymosin Alpha-1" OR CHEM:"Thymosin Alpha-1" OR TITLE_ABS:"Thymosin Alpha1" OR CHEM:"Thymosin Alpha1") OR (TITLE_ABS:"Thymosine Alpha 1" OR CHEM:"Thymosine Alpha 1" OR TITLE_ABS:"Thymosine Alpha1" OR CHEM:"Thymosine Alpha1") OR (TITLE_ABS:"Zadaxin" OR CHEM:"Zadaxin")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Thymosin Alpha-1 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/thymosin-alpha-1